Biomarkers

TECHNOLOGY: Tissue markers

Tumor levels of PHLDA1 could help predict resistance to RTK inhibitors in endometrial, breast and other cancers. In tumor samples from patients with metastatic breast cancer or locally advanced non-metastatic

Read the full 322 word article

User Sign In